UnitedHealth director Baker gets 257-unit stock grant
The director's deferred stock units vested immediately but must be retained until Board service ends.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
UnitedHealth Group Inc. director Charles D. Baker acquired 257 deferred stock units on October 1, 2026, as regular quarterly compensation for Board service. The units vested immediately but must be retained until he completes service on the Board. His reported position following the transaction was 2,668 shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock F1 | 257 | $0.00 | $0.00 |
Footnotes (1)
- F1. Represents deferred stock units that are granted as regular quarterly compensation for service as a director of UnitedHealth Group. Deferred stock units are immediately vested, but must be retained by the director until the director's completion of service on the Board.
Key Figures
Key Terms
deferred stock units financial
immediately vested financial
quarterly compensation financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many deferred stock units did UNH director Charles D. Baker receive?
What were Charles D. Baker’s reported UNH holdings after the transaction?
AI-generated analysis. How Rhea-AI works. Not financial advice.